Martingale Asset Management L P Syros Pharmaceuticals, Inc. Transaction History

Martingale Asset Management L P

  • $4.56 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 10, 2021
SELL
$6.66 - $14.66 $247,865 - $545,601
-37,217 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$8.69 - $14.47 $477,081 - $794,403
-54,900 Reduced 59.6%
37,217 $328,000
Q2 2020

Aug 10, 2020
BUY
$5.21 - $11.03 $479,929 - $1.02 Million
92,117 New
92,117 $981,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email